2010 Archive

Significant Progress Made in Advancing Company’s Small Molecules for the Treatment of Autoimmune Diseases; Appoints Chairman of the Board and Welcomes New Vice President in Preparation for Clinic Ann Arbor, Mich., and Cambridge, Mass. – April 28, 2010 — Lycera Corporation, a biopharmaceutical company pioneering an innovative approach to developing novel oral medicines to treat… Read More

Former Head of U.S. Commercial at Biogen Idec Will Lead Emerging Small Molecule Immunology Company in Next Phase of Growth Ann Arbor, Mich., and Cambridge, Mass. – January 7, 2010 — Lycera Corporation, a pharmaceutical company focused on developing novel small-molecule medicines to treat autoimmune diseases, today announced that William J. Sibold has been named… Read More